Trial intelligence / Profile preview

Onset of Action of Paroxetine in PMDD

NCT00516113Phase 4Completed

Sponsor
Karolinska Institutet
Start
Oct 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of paroxetine in Premenstrual Dysphoric Disorder (PMDD), sponsored by Karolinska Institutet. Started Oct 2000; status: completed.

02

Drugs

paroxetine
03

Conditions

Premenstrual Dysphoric Disorder (PMDD)

Beyond the preview

Go deeper on NCT00516113.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00516113.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call